Genomic mapping reveals cisplatin disruption of protein phosphorylation signalling genome-wide
Metallomics · 31.01.2026 · 18 (1)
DOI: 10.1093/mtomcs/mfag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metallomics, online erschienen am 05.06.2026. Verfasst von Luyu Qi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, CAS Research/Education Center for Excellence in Molecular Sciences, National Centre for Mass Spec…. Hauptthemen laut MEDLINE: Cisplatin, Signal Transduction, Chromosome Mapping, Antineoplastic Agents. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Scientific Instrument Developing Project of the Chinese Academy of Sciences.
Abstract (Originalsprache)
Cisplatin is a DNA-targeting chemotherapeutic. Here we investigate how the cisplatin-damaged gene (CDG) loci are linked to specific protein-driven signalling pathways. A human high mobility group protein 1 box a-based affinity probe has been constructed and 1,2-cisplatin-crosslinked DNA has been isolated before high throughput gene sequencing. Cisplatin damage to specific genes has been mapped in human lung cancer cells, and a total of 16 216 CDGs mapped with fold-enrichment >1.5. Surprisingly, bioinformatics analysis demonstrates that cisplatin targets most of the human protein kinase (PK) and phosphatase genes and is involved in 300 important cell signalling pathways (−log p > 4). The most associated key signalling pathways are sperm motility and protein kinase A. Notably, cisplatin damaged 85% (440) of human PK genes and 81% (110) of human protein phosphatase genes. This implies that cisplatin may disrupt protein phosphorylation signalling genome-wide, evidenced by a significant decrease in expression of a series of key PK genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, CAS Research/Education Center for Excellence in Molecular Sciences, National Centre for Mass Spectrometry in Beijing, CAS Key Laboratory of Analytical Chemistry for Li…
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Basic Medical College, Shandong University of Chinese Traditional Medicine, Jinan 250355, China.
- NGS Department, Sangon Biotech (Shanghai), Shanghai 201611, China.
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, United Kingdom.
- Beijing National Laboratory for Molecular Science, Huairou Research Center, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
ORCID-Profile: Peter J Sadler, Yao Zhao, Fuyi Wang
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Scientific Instrument Developing Project of the Chinese Academy of Sciences
- Anglo American Platinum
- EPSRC
Zitieren
APA
Qi, L., Luo, Q., Hou, Y., Xu, Y., Yu, W., Liu, X., Xin, B., Huang, Y., Li, X., Zhang, Y., Wang, S., Sadler, P. J., Zhao, Y., & Wang, F. (2026). Genomic mapping reveals cisplatin disruption of protein phosphorylation signalling genome-wide. Metallomics, 18(1). https://doi.org/10.1093/mtomcs/mfag016
Vancouver
Qi L, Luo Q, Hou Y, Xu Y, Yu W, Liu X, et al. Genomic mapping reveals cisplatin disruption of protein phosphorylation signalling genome-wide. Metallomics. 2026;18(1). doi:10.1093/mtomcs/mfag016
BibTeX
@article{Qi2026,
author = {Qi, Luyu and Luo, Qun and Hou, Yinzhu and Xu, Yan and Yu, Wanchen and Liu, Xingkai and Xin, Bobo and Huang, Yaolong and Li, Xiangjun and Zhang, Yanyan and Wang, Shijun and Sadler, Peter J and Zhao, Yao and Wang, Fuyi},
title = {Genomic mapping reveals cisplatin disruption of protein phosphorylation signalling genome-wide},
journal = {Metallomics},
year = {2026},
volume = {18},
number = {1},
doi = {10.1093/mtomcs/mfag016}
}
EUVIMED